What is NVO's current stock price?

As of now, NVO is trading at $48.00, with a daily change of -0.03%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO

Novo Nordisk A/S

$48.00

-$0.00 | -0.03%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$112.52

MKT CAP

$162.04B

52W Low

$43.08

VOL

$10.44M

P/E Ratio

16.35

AVG VOL

$20.09M

RSI

45.91

TREND

Downtrend

NVO Stock IQ

Login to see Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NVO Target Price

Login to display

Strengths

NVO Rewards

Earnings are forecast to grow

NVO Rewards

Trading below its fair value

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Investors confidence is positive

NVO Price Performance

$45.68 (+5.08%)

$54.3 (-11.60%)

$67.18 (-28.55%)

$105.96 (-54.70%)

1year

6month

3month

1month

NVO Risk Level

NVO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Hit 52-week low

Low

LOW

HIGH

NVO Analysts Opinion

NVO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

NVO Analysts Opinion

NVO Analysts opinion is positive and also has improved from the past 3 months

NVO Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

20%

75%

NVO Street Sentiment

NVO Street Sentiment is bullish and have positive views on the near-term outlook

NVO Performance Sentiment

Sentiments overview associated with NVO events and the stock performance.

55%

40%

Positive

Negative

33 out of 60
events present

24 out of 60
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$47.57

Resistance
Price

$44.97

Current Price Range

$53.12

Show methods +

Linked to NVO

IQ

Close Price

Change

LLY

4.13

1008.38

-0.60%

PFE

3.94

25.92

+0.86%

LEXX

3.50

1.09

-4.46%

VKTX

3.87

39.17

+1.63%

MRK

4.03

99.41

-1.50%

NVO Latest Analysis +

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM Owing to the Increasing Prevalence Awareness and Advancements in Gene Therapies | DelveInsight. Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM Owing to the Increasing Prevalence Awareness and Advancements in Gene Therapies |. DelveInsightThe sickle cell disease marke

Wed Dec 3, 2025

$47.57 | +0.30%

Activity

Potential

Medicare Just Cut the Price of Wegovy: Should You Sell Novo Nordisk Stock?. Key PointsThe government has just negotiated a significant price reduction for the diabetes and weight-loss treatment.

Wed Dec 3, 2025

$47.57 | +0.30%

Momentum

Omeros Novo Nordisk close up to $2.1B deal for phase 2 asset zaltenibart.

Mon Dec 1, 2025

$48.43 | -1.76%

Activity

Novo Nordisks Latest Clinical Result Is Sending the Stock Plunging. Heres What Investors Need to Know.. Key PointsSemaglutide failed to demonstrate slowed Alzheimer&rsquo.s progression in EVOKE/EVOKE preliminary results though some biomarkers improved.

Mon Dec 1, 2025

$48.43 | -1.76%

Momentum

Potential

Novo Nordisk: A Textbook Value Trap.

Fri Nov 28, 2025

$49.35 | +1.31%

Potential

Why Novo Nordisk Stock Is Moving Higher Today. Key PointsNovo Nordisk is seeking FDA approval for a 7.2 mg dose of Wegovy nearly three times the current maximum dose.

Wed Nov 26, 2025

$48.71 | +3.51%

Activity

Novo Nordisk Wants FDA Nod For A Higher-Dose Wegovy. On Wednesday ) submitted its supplemental marketing application to the United States Food and Drug Administration (FDA) for a higher dose of semaglutide injection 7.2 mg for .NVO is among today'.s top performers. The new higher dose of Wegovy (semaglutide 7.2 mg) is currently under review with the European Medicines Agency in the United Kingdom and several other countries.In the EU Novo Nordisk expects a regulatory decision in Q1 2026.Unde

Wed Nov 26, 2025

$48.71 | +3.51%

Activity

NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes. Novo Nordisk jumps after phase II data show amycretin offers significant weight loss and HbA1c level reductions in type 2 diabetes patients.

Wed Nov 26, 2025

$48.71 | +3.51%

Momentum

Novo Nordisk: Buying The 2024 Dip Was All Wrong (Downgrade).

Wed Nov 26, 2025

$48.71 | +3.51%

Momentum

Medicare Slashes Ozempics Price Tag 71%. Why Novo Nordisk Rallied.

Wed Nov 26, 2025

$48.71 | +3.51%

Momentum

FAQ About NVO Stock Insights

What is NVO current stock price?

What are NVO stock strengths?

What is NVO Risk Level?

What is NVO market cap and volume?

What is NVO current Stock IQ?

Should I buy NVO stock right now?

Is NVO a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVO?

What does a 'Strong Sell' rating mean for NVO?

What factors influence NVO's Stock IQ?

Explore our NVO Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored NVO Stock Strategies
Effective Risk Management

FIND US ON

Receive our NVO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

NVO

Novo Nordisk A/S

Current Price

$48.00

-$0.00 | -0.03%

52W High

$112.52

MKT CAP

$162.04B

52W Low

$43.08

VOL

$10.44M

P/E Ratio

16.35

AVG VOL

$20.09M

RSI

45.91

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

NVO Rewards

Earnings are forecast to grow

NVO Rewards

Trading below its fair value

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Investors confidence is positive

Linked to NVO

Symbol

IQ

Close

Change

LLY

4.13

1008.38

-0.60%

PFE

3.94

25.92

+0.86%

LEXX

3.50

1.09

-4.46%

VKTX

3.87

39.17

+1.63%

MRK

4.03

99.41

-1.50%

NVO Price Performance

$45.68 (+5.08%)

$54.3 (-11.60%)

$67.18 (-28.55%)

$105.96 (-54.70%)

1year

6month

3month

1month

NVO Analysts Opinion

NVO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

NVO Analysts Opinion

NVO Analysts opinion is positive and also has improved from the past 3 months

NVO Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

20%

75%

NVO Street Sentiment

NVO Street Sentiment is bullish and have positive views on the near-term outlook

NVO Risk Level

NVO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Hit 52-week low

Low

LOW

HIGH

NVO Performance Sentiment

Sentiments overview associated with NVO events and the stock performance.

55%

40%

Positive

Negative

33 out of 60
events present

24 out of 60
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$47.57

Resistance
Price

$44.97

Current Price Range

$53.12

Show methods +

NVO Stock IQ

Login to unlock Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NVO Latest Analysis

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM Owing to the Increasing Prevalence Awareness and Advancements in Gene Therapies | DelveInsight. Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM Owing to the Increasing Prevalence Awareness and Advancements in Gene Therapies |. DelveInsightThe sickle cell disease marke

Wed Dec 3, 2025

$47.57 | +0.30%

Activity

Potential

Medicare Just Cut the Price of Wegovy: Should You Sell Novo Nordisk Stock?. Key PointsThe government has just negotiated a significant price reduction for the diabetes and weight-loss treatment.

Wed Dec 3, 2025

$47.57 | +0.30%

Momentum

Omeros Novo Nordisk close up to $2.1B deal for phase 2 asset zaltenibart.

Mon Dec 1, 2025

$48.43 | -1.76%

Activity

Novo Nordisks Latest Clinical Result Is Sending the Stock Plunging. Heres What Investors Need to Know.. Key PointsSemaglutide failed to demonstrate slowed Alzheimer&rsquo.s progression in EVOKE/EVOKE preliminary results though some biomarkers improved.

Mon Dec 1, 2025

$48.43 | -1.76%

Momentum

Potential

Novo Nordisk: A Textbook Value Trap.

Fri Nov 28, 2025

$49.35 | +1.31%

Potential

Why Novo Nordisk Stock Is Moving Higher Today. Key PointsNovo Nordisk is seeking FDA approval for a 7.2 mg dose of Wegovy nearly three times the current maximum dose.

Wed Nov 26, 2025

$48.71 | +3.51%

Activity

Novo Nordisk Wants FDA Nod For A Higher-Dose Wegovy. On Wednesday ) submitted its supplemental marketing application to the United States Food and Drug Administration (FDA) for a higher dose of semaglutide injection 7.2 mg for .NVO is among today'.s top performers. The new higher dose of Wegovy (semaglutide 7.2 mg) is currently under review with the European Medicines Agency in the United Kingdom and several other countries.In the EU Novo Nordisk expects a regulatory decision in Q1 2026.Unde

Wed Nov 26, 2025

$48.71 | +3.51%

Activity

NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes. Novo Nordisk jumps after phase II data show amycretin offers significant weight loss and HbA1c level reductions in type 2 diabetes patients.

Wed Nov 26, 2025

$48.71 | +3.51%

Momentum

Novo Nordisk: Buying The 2024 Dip Was All Wrong (Downgrade).

Wed Nov 26, 2025

$48.71 | +3.51%

Momentum

Medicare Slashes Ozempics Price Tag 71%. Why Novo Nordisk Rallied.

Wed Nov 26, 2025

$48.71 | +3.51%

Momentum

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVO. We're here to help you make informed investment decisions today.

FIND US ON

Receive our NVO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVO Stock trends

NVO Stock performance

NVO Stock analysis

NVO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO Stock IQ

NVO Target Price

NVO Risk Level

NVO Analysts Opinion

NVO Street Sentiment

NVO Performance Sentiment

Technical Price Levels

Explore our NVO Stock insights

Receive our NVO Daily Alerts

NVO Street Sentiment

NVO Risk Level

Technical Price Levels

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVO. We're here to help you make informed investment decisions today.

Receive our NVO Daily Alerts

NVO Runner Alarm